相关实验视频

Updated: Jun 9, 2025

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Published on: January 7, 2019

CTLA-4多态与血液恶性瘤易感性的关联:一个元分析

Xuefen Yan¹, Nana Zhang¹, Gang Wang¹

¹Department of Hematology, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.

Frontiers in oncology

|October 28, 2024

概括

细胞毒性T淋巴细胞抗原-4 (CTLA-4) 49A/G和319C/T基因变异与血液性恶性瘤风险有关. 这一元分析澄清了它们与对某些血液癌症敏感性增加的关联.

科学领域:

免疫遗传学免疫遗传学
在瘤学瘤学.
遗传流行病学遗传流行病学

背景情况:

细胞毒性T-淋巴细胞抗原-4 (CTLA-4) 基因多态性已被研究出它们在血液恶性瘤易感性中的作用.
以前的研究报告了相互矛盾的结果,需要进行全面的分析.

研究的目的:

进行一项元分析,研究各种CTLA-4多态性和对血液恶性瘤的易感性之间的关联.
为了澄清先前研究中不一致的发现.

主要方法:

在主要数据库 (Cochrane Library,PubMed,Embase) 进行了系统的文献搜索,截至2024年9月20日.
聚合赔率比率 (OR) 和95%置信区间 (CI) 计算以评估关联的强度.
使用STATA 12.0.0进行统计分析.

主要成果:

分析包括13项研究,研究CTLA-4多态:49A/G,60A/G,318T/C,1661A/G和319C/T.
CTLA-4 49A/G多态性与血液恶性瘤风险增加显著相关 (OR = 1.77,95% CI = 1.56-2.02),特别是在非霍奇金淋巴瘤,多发性髓瘤和白血病中.
CTLA-4 319C/T多态性与慢性淋巴细胞白血病风险降低有关. 对于CTLA-4 60A/G,318T/C和1661A/G多态,没有发现显著的关联.

结论:

CTLA-4 49A/G和319C/T多态性与血液恶性瘤易感性显著相关.
这些发现有助于了解影响血液癌症风险的遗传因素.

关键词:

在 CTLA-4 中.血性恶性瘤血性恶性瘤这种白血病是白血病.这是一个元分析.多形态主义的多态主义.

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...